WO1996037113A1 - Yoghurt containing bifidobacterium and process for producing the same - Google Patents
Yoghurt containing bifidobacterium and process for producing the same Download PDFInfo
- Publication number
- WO1996037113A1 WO1996037113A1 PCT/JP1996/001401 JP9601401W WO9637113A1 WO 1996037113 A1 WO1996037113 A1 WO 1996037113A1 JP 9601401 W JP9601401 W JP 9601401W WO 9637113 A1 WO9637113 A1 WO 9637113A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- yogurt
- bifidobacterium
- fish oil
- added
- culture
- Prior art date
Links
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 58
- 241000186000 Bifidobacterium Species 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims description 8
- 230000008569 process Effects 0.000 title description 3
- 235000021323 fish oil Nutrition 0.000 claims abstract description 35
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000005487 catechin Nutrition 0.000 claims abstract description 25
- 150000001765 catechin Chemical class 0.000 claims abstract description 22
- 239000011732 tocopherol Substances 0.000 claims abstract description 17
- 229930003799 tocopherol Natural products 0.000 claims abstract description 16
- 235000019149 tocopherols Nutrition 0.000 claims abstract description 12
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims abstract description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
- 241000894006 Bacteria Species 0.000 claims description 30
- 235000020357 syrup Nutrition 0.000 claims description 23
- 239000006188 syrup Substances 0.000 claims description 23
- 235000014655 lactic acid Nutrition 0.000 claims description 19
- 239000004310 lactic acid Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 235000013336 milk Nutrition 0.000 claims description 13
- 239000008267 milk Substances 0.000 claims description 13
- 210000004080 milk Anatomy 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000014347 soups Nutrition 0.000 claims 1
- 230000004083 survival effect Effects 0.000 abstract description 8
- 230000002730 additional effect Effects 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 11
- 239000007858 starting material Substances 0.000 description 11
- 238000003860 storage Methods 0.000 description 11
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 9
- 229940090949 docosahexaenoic acid Drugs 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 8
- 235000020183 skimmed milk Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000013861 fat-free Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 150000002206 flavan-3-ols Chemical class 0.000 description 2
- 235000011987 flavanols Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000020299 breve Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- -1 paratinit Chemical compound 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000013948 strawberry juice Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Definitions
- the present invention relates to a yogurt containing a lactic acid bacterium and a bifidobacterium.
- yogurt is produced by causing lactic acid fermentation of lactic acid bacteria in animal milk, but yogurt (or fermented milk produced only by bifidobacteria) obtained by inoculating milk with lactic acid bacteria and bifidobacterium bacteria.
- yogurt obtained by mixing with fermented milk from lactic acid bacteria contains not only lactic acid bacteria but also bifidobacteria and is expected to have various useful effects unique to these bacteria. ing.
- Bifidobacterium is an obligate anaerobic bacterium, which is affected by a small amount of oxygen entering the container, and has poor acid resistance and is easily killed in acidic yogurt.
- yogurt containing Bifidobacterium a container with good oxygen-barrier properties should be used to maintain an environment favorable for the growth of this bacterium, and monosaccharides that deteriorate viability should not be used as sweeteners.
- various considerations have been made, but nonetheless, the reduction in the number of viable bacteria of Bifidobacterium progresses remarkably in comparison with lactic acid bacteria.
- an object of the present invention is to improve the viability of Bifidobacterium compared to conventional products.
- An object of the present invention is to provide yogurt containing bifidobacterium.
- Another object of the present invention is to add a refined fish oil having good flavor and excellent quality stability, which has good viability of Bifidobacterium bacteria and almost no fishy odor during the expected storage period.
- catechins and / or tocoproles are preferably contained in each of the glutes in an amount of about 0.1 to 200 ppm, respectively. The same applies when adding refined fish oil to yogurt.
- the catechins include flavanols containing catechol as partial structures (so-called catechins), flavanols containing pyrogallol (so-called gallocatechin), and gallic esters thereof.
- tocopherols include d- ⁇ -tocopherol which is a synthetic product, d- ⁇ -form, body, y-form, etc. tocopherol obtained from wheat germ, soybean, corn, and the like, and a mixture thereof. .
- Bifidobacterium is preferably mixed and cultured with lactic acid bacteria. That is, at the start of lactic acid fermentation, a bifidobacterium is inoculated into a milk medium together with lactic acid bacteria. Catechins and / or tocofurols and further refined fish oil are added to the obtained culture. Preferably, these additives are dissolved together with a sweetener in a sweetener for sweetening. deep.
- the strength techins and tocopherols added to yogurt according to the present invention improve the viability of Bifidobacterium bacteria without deteriorating the flavor of yogurt.
- the form of the yogurt of the present invention is not limited, and may be any of liquid yogurt for drinking, solid yogurt eaten using a spoon, and frozen yogurt.
- the method for producing yogurt according to the present invention will be described focusing on the most advantageous method.
- the manufacturing method is not limited to this.
- the raw material milk (reduced skim milk, whole milk, skim milk, etc.) used as a medium is adjusted to a non-fat milk solid concentration of about 10 to 30%, and if necessary, yeast extract etc.
- Add a growth-promoting substance sterilize by heating in the usual manner, cool, and load into a fermentation tank. Then, an appropriate amount of a starter is added, and fermentation is started under anaerobic conditions while maintaining the temperature at about 30 to 40 ° C. Once the culture has reached the target acidity, it is cooled to stop the fermentation.
- the resulting mixed culture is mixed with refined fish oil, catechins, and / or tokoff X-rolls when refined fish oil is added.
- These additives may be used alone or in the form of a solution or an emulsified liquid, respectively, and may be added and mixed to the above culture. It is advantageous to add it to the bottle. That is, refined fish oil, catechins and tocopherols are also added to syrup in the same way that syrup contains most of the added ingredients such as fruit juice and growth promoting substances for Bifidobacterium bacteria when producing ordinary liquid yogurt.
- the mixing of all the added components is completed in one mixing operation, the amount of oxygen mixed into the product can be reduced, which is advantageous from the viewpoint of improving the survival of Bifidobacterium.
- catechins and tocopherols are most effective in preventing fish odor when the above-mentioned method is used, in which all ingredients including refined fish oil are added to syrup. .
- the purified fish oil preferably has a high content of highly unsaturated fatty acids such as DHA and EPA. Those having an A content (in the case of an emulsion, based on the amount of fish oil therein) of about 15% or more are particularly preferred.
- the refined fish oil is desirably formulated so that about 0.05 to 0.2% of DHA is contained in yogurt.
- Catechins are effective in improving the survival of Bifidobacterium at a concentration of 0.1 ppm or more with respect to yogurt, and are effective at preventing fish odor at a concentration of 100 ppm or more with refined fish oil.
- the content of yogurt exceeds 2000 ppm, astringency and bitterness may be felt, and moreover, it may exhibit an antibacterial effect and may worsen the viability of bifidobacterium and lactic acid bacteria. Be careful not to add more than necessary.
- tocopherols synthetic products commercially available for the production of vitamin E preparations or for the addition of foods, d1- ⁇ -tocopherol, and mixtures of various natural tocopherols and the like can be used.
- Tocoproles have an effect of improving the survival of Bifidobacterium bacteria at 0.1 ppm or more against yogurt, and are effective at preventing fish odor generation at 100 ppm or more against refined fish oil. However, if it exceeds 2000 ppm for yogurt, it may be separated in the product or the flavor may be deteriorated. Therefore, it is desirable to take care not to add more than necessary amount.
- sweeteners are sucrose, maltose, lactose, palatinose, trehalose, trehalulose, galacto-oligosaccharide, sorbitol, maltitol, paratinit, glycyrrhizin, stepioside, rebaudioside, saccharin, aspartame, acesulfame. K, water Candy, reduced syrup, etc. Two or more of these sweeteners may be used in combination from the viewpoint of improving sweetness and the like.
- the syrup to which the sweetener and other additives have been added is heat-sterilized in a conventional manner, cooled, and after sterilization, if any, is added, and then mixed with the aforementioned milk culture.
- Milk culture mixed with syrup, etc. is immediately filled into an oxygen-barrier container.
- an oxygen-barrier container it is desirable not to leave oxygen-containing air in the container when filling the milk culture with the container.
- One effective means for this is to perform full filling without leaving any space above the container. If full filling is not possible, it is effective to replace the air in the upper space with an inert gas such as nitrogen.
- the techins used were the purified tea extract of Taiyo Kagaku Co., Ltd. Sanfunon (catechins content: about 70%; catechins, gallocatins, and gallic esters thereof). Yes, and the refined fish oil used was an emulsion with a fish oil content of 20% and a DHA content of about 5%.
- Heat-sterilized 25% reduced skim milk (350 g) was inoculated with 1% of Lactobacillus acidophilus starter and 1% of Bifidobacterium bifidum starter at 37 ° C until the pH reached 5.2. After culturing, cool it. On the other hand, water is added to 50 g of ginseng juice, 50 g of sugar, and 0.6 mg of catechins to make a total amount of 65500 g, thereby obtaining a syrup containing phytotechins. This syrup is sterilized by heating, mixed with the culture obtained by the above culture, and filled in an oxygen-barrier container. In the above yogurt production process, a purified fish oil containing 150 mg of DHA is added to any of the following.
- yogurt was prepared in the same manner as above, except that no kinetics were added.
- tocopherols used are those with a total tocopherol content of 80%, which are commercially available for the production of vitamin E preparations, and a tocopherol content of about 40%. After storage for 14 days for each yogurt, the viable cell count of Bifidobacterium was measured and the flavor was examined. The results are shown in Table 3.
- the obtained drink yogurt (3.8 x 10 V ml of viable bacteria bacteria) is filled in a sealed oxygen-blocking container and stored at 10 ° C for 14 days.
- the viable bacteria number of bacteria is 4.9 x 10 7 / ml And the flavor was also good.
- the culture in which the purified fish oil and the syrup were mixed was homogenized at 150 kg Z cm 2 and then filled in an oxygen-tight sealed container.
- the obtained drink yoghurt (Bifidobacterium viable cell count 3.21 O m 1) did not show any fishy odor even after being stored at 10 ° C for 14 days, and the viable bacterial cell count in it was 6.0 X 1 Om1 was maintained.
- the cells were inoculated with 1% and cultured until 1311 became 5.3.
- ginseng juice 50 g of ginseng juice, 120 g of palatinose, lmg of catechins, tocoproles (total content of tocopherol 80%, (5-tocopherol content of about 25%, ⁇ -tocopherol content of about 15%) lmg, and DHA of 100 Water was added to mg of purified fish oil to make the total amount 650 g, and the mixture was heated to 120 ° C for 3 seconds to kill bacteria, and then cooled to 10 ° C or less.
- the resulting syrup was mixed with the culture of the above culture, and the resulting drink (3.5 x 10 8 Zml of Bifidobacterium viable bacteria) was sealed in an oxygen-tight seal.
- the container was filled and stored at 10 ° C. 14 After opening and inspecting, the product showed no fishy odor at all, and the viable bacterial count of Bifidobacterium was maintained at 5.3x10 m1.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Dairy Products (AREA)
Abstract
Catechins and/or tocopherols are added each in an amount of about 0.1 to 2,000 ppm to a yoghurt containing Bifidobacterium to thereby improve the survival properties of the Bifidobacterium. When the yoghurt is one containing refined fish oil, there is achieved an additional effect of suppressing the generation of an offensive odor due to the fish oil. Thus the stability of the qualities of the yoghurt can be improved.
Description
明 細 書 Specification
ビフィ ドバクテリゥム菌を含有するョーグルト及びその製造法 Yogurt containing bifidobacterium and method for producing the same
技術分野 Technical field
本発明は、 乳酸菌と共にビフィ ドバクテリゥム菌を含有するヨーグルトに関す るものである。 The present invention relates to a yogurt containing a lactic acid bacterium and a bifidobacterium.
背景技術 Background art
ョ一グルトは本来獣乳に乳酸菌による乳酸発酵を生じさせて製造されるもので あるが、 乳酸菌と共にビフィ ドバクテリゥム菌を乳に接種して得られるョーグル ト (あるいはビフィ ドバクテリゥム菌のみによる発酵乳を乳酸菌による発酵乳に 混合して得られる類似のヨーグルト) は、 乳酸菌だけでなくビフィ ドバクテリウ ム菌をも含有することによりこの細菌特有の種々の有用作用が期待されるため、 近年その消費量が増大している。 Originally, yogurt is produced by causing lactic acid fermentation of lactic acid bacteria in animal milk, but yogurt (or fermented milk produced only by bifidobacteria) obtained by inoculating milk with lactic acid bacteria and bifidobacterium bacteria. The similar yogurt obtained by mixing with fermented milk from lactic acid bacteria contains not only lactic acid bacteria but also bifidobacteria and is expected to have various useful effects unique to these bacteria. ing.
しかしながら、 このビフィ ドバクテリゥム菌入りヨーグルトが工場で製造され たあと流通過程を経て飲食される時まで、 ビフィ ドバクテリゥム菌の生菌数を一 定の水準に維持することは、 乳酸菌の場合よりも著しく困難である。 これは、 ビ フィ ドバクテリゥム菌が偏性嫌気性菌であって、 容器に入り込んだ微量の酸素に よっても影響を受けること、 および、 耐酸性が悪く、 酸性のヨーグルト中では死 滅し易い とによる。 However, it is much more difficult to maintain the viable bacterial count of Bifidobacterium at a constant level until it is consumed through the distribution process after the yogurt containing the Bifidobacterium is manufactured in the factory than in the case of lactic acid bacteria. It is. This is because Bifidobacterium is an obligate anaerobic bacterium, which is affected by a small amount of oxygen entering the container, and has poor acid resistance and is easily killed in acidic yogurt.
したがって、 ビフィ ドバクテリゥム菌を含有するヨーグルトには、 この菌の生 育に好都合な環境を維持するため酸素遮断性の良い容器を用い、 生残性を悪くす る単糖類は甘味料として使わないなど、 さまざまな配慮がなされているが、 それ でも、 ビフィ ドバクテリゥム菌の生菌数減少は乳酸菌と比べると顕著に進行する のが現状である。 Therefore, for yogurt containing Bifidobacterium, a container with good oxygen-barrier properties should be used to maintain an environment favorable for the growth of this bacterium, and monosaccharides that deteriorate viability should not be used as sweeteners. However, various considerations have been made, but nonetheless, the reduction in the number of viable bacteria of Bifidobacterium progresses remarkably in comparison with lactic acid bacteria.
また、 近年、 循環器系疾患等の予防や治療に有効なドコサへキサェン酸 (D H A) その他の高度不飽和脂肪酸を含有する精製魚油を各種食品に添加することが 行われるようになつたが、 ビフィ ドバクテリゥム菌含有ヨーグルトに精製魚油を 添加してこのョーグルトの健康維持 ·増進作用を一層強化しょうとする場合、 製 品の品質安定性を確保する上で新たな課題が生じることが判った。 すなわち、 ョ 一グルトに精製魚油を添加した場合、 保存期間が長くなると魚臭の発現が避けら れず、 本来淡泊なョ一グルトの風味が著しく損なわれてしまう。 In recent years, refined fish oils containing docosahexaenoic acid (DHA) and other highly unsaturated fatty acids, which are effective in preventing and treating cardiovascular diseases, have been added to various foods. When refined fish oil was added to yogurt containing Bifidobacterium to further enhance the health maintenance and enhancement effects of this yogurt, it was found that there was a new problem in ensuring the quality stability of the product. In other words, when refined fish oil is added to the yogurt, if the storage period is prolonged, the development of fish odor is inevitable, and the flavor of the originally light-yield yogurt is significantly impaired.
そこで本発明の目的は、 従来品よりもビフィ ドバクテリゥム菌の生残性が良い
ビフィ ドバクテリゥム菌含有ョーグルトを提供することにある。 Therefore, an object of the present invention is to improve the viability of Bifidobacterium compared to conventional products. An object of the present invention is to provide yogurt containing bifidobacterium.
本発明の他の目的は、 ビフィ ドバクテリゥム菌の生残性が良く、 しかも、 通常 期待される保存期間中は魚臭をほとんど感じさせることのない、 風味良好で品質 安定性に優れた精製魚油添加ビフィ ドバクテリウム菌含有ョ一グルトを提供する とにめる。 Another object of the present invention is to add a refined fish oil having good flavor and excellent quality stability, which has good viability of Bifidobacterium bacteria and almost no fishy odor during the expected storage period. Providing Bifidobacterium-containing yeast glut.
発明の開示 Disclosure of the invention
上記課題を解決する手段として、 本発明ではョ一グルトにカテキン類および/ またはトコフヱロール類を、 好適にはそれぞれ 0. 1〜2 0 0 0 p p m程度含有 させる。 ヨーグルトに精製魚油を添加する場合においても同様にする。 As a means for solving the above-mentioned problems, in the present invention, catechins and / or tocoproles are preferably contained in each of the glutes in an amount of about 0.1 to 200 ppm, respectively. The same applies when adding refined fish oil to yogurt.
ここでカテキン類とは、 部分構造としてカテコールを含むフラバノール (いわ ゆるカテキン) とピロガロールを含むフラバノール (いわゆるガロカテキン) 、 およびこれらの没食子酸エステルを包含する。 また、 トコフエロール類とは、 合 成品である d \ - a -トコフヱロールのほか、 小麦胚芽、 大豆、 トウモロコシ等 から得られる d— α体、 体、 y体等のトコフヱロール、 およびこれらの混合物 を意味する。 Here, the catechins include flavanols containing catechol as partial structures (so-called catechins), flavanols containing pyrogallol (so-called gallocatechin), and gallic esters thereof. In addition, tocopherols include d-α-tocopherol which is a synthetic product, d-α-form, body, y-form, etc. tocopherol obtained from wheat germ, soybean, corn, and the like, and a mixture thereof. .
このヨーグルトを製造する場合、 ビフィ ドバクテリゥム菌は望ましくは乳酸菌 と混合培養する。 すなわち、 乳酸発酵の開始時に、 乳酸菌と共にビフィ ドバクテ リウム菌を乳培地に接種する。 得られた培養物に、 カテキン類および (または) トコフ ロール類、 さらには精製魚油を添加するが、 好適には、 これらの添加物 は甘味付けのためのシ口ップに甘味料と共に溶かしておく。 When producing this yogurt, Bifidobacterium is preferably mixed and cultured with lactic acid bacteria. That is, at the start of lactic acid fermentation, a bifidobacterium is inoculated into a milk medium together with lactic acid bacteria. Catechins and / or tocofurols and further refined fish oil are added to the obtained culture. Preferably, these additives are dissolved together with a sweetener in a sweetener for sweetening. deep.
本発明によりョーグルトに添加された力テキン類およびトコフエロール類は、 I、ずれもョーグルトの風味を悪化させることなしにビフィ ドバクテリゥム菌の生 残性を向上させる。 The strength techins and tocopherols added to yogurt according to the present invention improve the viability of Bifidobacterium bacteria without deteriorating the flavor of yogurt.
また、 ヨーグルトに精製魚油が添加されている場合は、 ビフィ ドバクテリゥム 菌の生残性を向上させるだけでなく、 保存期間が長くなった該ヨーグルトが魚臭 を感じさせるようになるのを防止する。 In addition, when refined fish oil is added to the yogurt, not only the survival of Bifidobacterium bacteria is improved, but also the yogurt whose storage period has been extended is prevented from having a fishy odor.
本発明のヨーグルトの形態に制限はなく、 飲用に供される液状ヨーグルト、 ス プーンを用いて食べる固形ヨーグルトおよび凍結ョーグルト等、 いずれであって もよい。 The form of the yogurt of the present invention is not limited, and may be any of liquid yogurt for drinking, solid yogurt eaten using a spoon, and frozen yogurt.
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明によるヨーグルトの製造法について、 最も有利な方法を中心に詳
述するが、 製造法がこれに限定されるわけではない。 Hereinafter, the method for producing yogurt according to the present invention will be described focusing on the most advantageous method. As mentioned, the manufacturing method is not limited to this.
ビフィ ドバクテリゥム菌入りヨーグルトを製造する場合、 乳酸菌とビフィ ドバ クテリウム菌は別々に培養してから培養物を混合するほうが培養そのものは容易 であるが、 乳酸菌のスターターとビフィ ドバクテリゥム菌のスターターを同じ乳 培地に接種して培養するほうが製品のビフィ ドバクテリウム菌の生残性がよいの で、 本発明においてはこの混合培養法を採用することが望ましい。 使用するビフィ ドバクテリゥム菌の菌種に制限はなく、 ョ一グルト製造に適した種たとえばビフィ ドバクテリゥム · ビフィダム、 同ロンガム、 同ブレーべ、 同ィンフアンテイス、 同ァドレツセンティス等を、 いずれも使用することができる。 When producing yogurt containing Bifidobacterium, it is easier to culture the lactic acid bacteria and Bifidobacterium bacteria separately and then mix the culture, but the lactic acid bacteria starter and the Bifidobacterium starter are used in the same milk medium. In the present invention, it is desirable to employ this mixed culture method, since the survival of Bifidobacterium in the product is better when the product is inoculated and cultured. There is no limitation on the species of Bifidobacterium to be used, and any species suitable for the production of yeast must be used, such as Bifidobacterium bifidum, Longam, Blebe, Infantace, Adletuscentis, etc. Can be.
混合培養の場合、 培地とする原料乳 (還元脱脂乳、 全乳、 脱脂乳等) は、 無脂 乳固形分濃度を約 1 0〜3 0 %に調整し、 必要に応じて酵母エキス等の生育促進 物質を添加し、 常法により加熱殺菌後、 冷却して発酵タンクへ装入する。 次いで 適量のスターターを添加し、 約 3 0〜4 0 °Cに保って嫌気性条件下に発酵を開始 させる。 培養物が目標酸度に達したならば冷却して発酵を停止させる。 In the case of mixed culture, the raw material milk (reduced skim milk, whole milk, skim milk, etc.) used as a medium is adjusted to a non-fat milk solid concentration of about 10 to 30%, and if necessary, yeast extract etc. Add a growth-promoting substance, sterilize by heating in the usual manner, cool, and load into a fermentation tank. Then, an appropriate amount of a starter is added, and fermentation is started under anaerobic conditions while maintaining the temperature at about 30 to 40 ° C. Once the culture has reached the target acidity, it is cooled to stop the fermentation.
得られた混合培養物に、 精製魚油を添加する場合における精製魚油、 カテキン 類、 または (および) トコフ Xロール類を混合する。 これらの添加成分は、 溶液 状または乳化液状のものをそれぞれ単独に上記培養物に添加混合してもよいが、 製品の甘味付けのためにシロップを添加する場合においては一部または全部をシ 口ップに添加しておくのが有利である。 すなわち、 通常の液状ヨーグルトを製造 するときシロップに果汁、 ビフィ ドバクテリゥム菌の生育促進物質等、 大部分の 添加成分を含有させるのと同様に、 精製魚油、 カテキン類およびトコフエロール 類もこのシロップに添加しておき、 1回の混合操作ですベての添加成分の混合が 終わるようにすると、 製品に対する酸素混入量を少なくすることができ、 ビフィ ドバクテリゥム菌の生残性向上の観点から有利である。 The resulting mixed culture is mixed with refined fish oil, catechins, and / or tokoff X-rolls when refined fish oil is added. These additives may be used alone or in the form of a solution or an emulsified liquid, respectively, and may be added and mixed to the above culture. It is advantageous to add it to the bottle. That is, refined fish oil, catechins and tocopherols are also added to syrup in the same way that syrup contains most of the added ingredients such as fruit juice and growth promoting substances for Bifidobacterium bacteria when producing ordinary liquid yogurt. In addition, if the mixing of all the added components is completed in one mixing operation, the amount of oxygen mixed into the product can be reduced, which is advantageous from the viewpoint of improving the survival of Bifidobacterium.
特に、 精製魚油を添加する場合は、 精製魚油を含むすべての添加成分をシロッ プに添加しておく上述の方法を採用した場合、 カテキン類およびトコフエロール 類の魚臭発生防止効果が最も顕著になる。 In particular, when refined fish oil is added, catechins and tocopherols are most effective in preventing fish odor when the above-mentioned method is used, in which all ingredients including refined fish oil are added to syrup. .
市販されている精製魚油には乳化物にしたものと油状のままのものとがあり、 いずれも本発明において使用することができるが、 乳化物のほうがシロップに均 一分散させ易く、 且つ魚臭を生じにくいので、 好ましい。 いうまでもなく精製魚 油は D H A、 E P A等の高度不飽和脂肪酸の含有率の高いものが好ましく、 D H
A含有率 (乳化物の場合はその中の魚油量基準の含有率) が約 1 5 %以上のもの が、 特に好ましい。 Commercially available refined fish oils include those in the form of emulsions and those that remain oily, and both can be used in the present invention. Emulsions are easier to disperse evenly in syrup and have a fishy odor. This is preferable because it is difficult to cause Needless to say, the purified fish oil preferably has a high content of highly unsaturated fatty acids such as DHA and EPA. Those having an A content (in the case of an emulsion, based on the amount of fish oil therein) of about 15% or more are particularly preferred.
精製魚油は、 D H Aとして約 0. 0 0 5〜0. 2 %がヨーグルトに含まれるよう に配合されることが望ましい。 The refined fish oil is desirably formulated so that about 0.05 to 0.2% of DHA is contained in yogurt.
カテキン類としては高純度の精製品を使用する必要はなく、 ヨーグルトの風味 に悪影響を与えないものであればカテキン類含有率がそれほど高くない植物抽出 物、 たとえば緑茶熱水抽出物、 ウーロン茶熱水抽出物、 またはそれらに簡単な精 製処理を施した程度のものでもそのまま使用することができる。 緑茶熱水抽出物 は、 カテキン類以外にも未確認の有効成分を含むと推察され、 本発明において力 テキン類を添加するための材料として好ましい。 使用可能な市販品の例としては、 サンフニノン (太陽化学株式会社製品)、サンウーロン (サントリー株式会社製 品) 等がある。 It is not necessary to use high-purity purified products as catechins, and plant extracts with low catechin content, such as green tea hot water extract and oolong tea hot water, as long as they do not adversely affect the flavor of yogurt Extracts or those obtained by subjecting them to a simple purification treatment can be used as they are. The green tea hot water extract is presumed to contain an unidentified active ingredient in addition to the catechins, and is preferred as a material for adding techchins in the present invention. Examples of commercially available products that can be used include Sanfuninone (manufactured by Taiyo Chemical Co., Ltd.) and Sun Oolong (manufactured by Suntory Limited).
カテキン類は、 ヨーグルトに対して 0. 1 p p m以上でビフィ ドバクテリゥム 菌の生残性向上に効果を示し、 精製魚油に対して 1 0 0 0 p p m以上で魚臭発生 防止に有効である。 しかしながら、 ヨーグルトに対して 2 0 0 0 p p mを超える と渋味や苦味を感じさせ、 さらに抗菌作用を示すようになってビフィ ドバクテリ ゥム菌や乳酸菌の生残性をかえって悪化させることがあるので、 必要量以上に添 加しないよう注意する。 Catechins are effective in improving the survival of Bifidobacterium at a concentration of 0.1 ppm or more with respect to yogurt, and are effective at preventing fish odor at a concentration of 100 ppm or more with refined fish oil. However, if the content of yogurt exceeds 2000 ppm, astringency and bitterness may be felt, and moreover, it may exhibit an antibacterial effect and may worsen the viability of bifidobacterium and lactic acid bacteria. Be careful not to add more than necessary.
トコフエロール類としては、 ビタミン E製剤製造用もしくは食品添加用に市販 されている合成品 · d 1— α—トコフヱロールや、 それと各種天然トコフヱ口一 ルの混合物等を使用することができる。 As tocopherols, synthetic products commercially available for the production of vitamin E preparations or for the addition of foods, d1-α-tocopherol, and mixtures of various natural tocopherols and the like can be used.
トコフヱロール類は、 ヨーグルトに対して 0. 1 ρ p m以上でビフィ ドバクテ リゥム菌の生残性向上に効果を示し、 精製魚油に対して 1 0 0 0 p p m以上で魚 臭発生防止に有効である。 しかしながら、 ヨーグルトに対して 2 0 0 0 p p mを 超えると製品中で分離したり風味を悪化させたりすることがあるので、 これも必 要量以上には添加しないように注意することが望ましい。 Tocoproles have an effect of improving the survival of Bifidobacterium bacteria at 0.1 ppm or more against yogurt, and are effective at preventing fish odor generation at 100 ppm or more against refined fish oil. However, if it exceeds 2000 ppm for yogurt, it may be separated in the product or the flavor may be deteriorated. Therefore, it is desirable to take care not to add more than necessary amount.
甘味科としては、 グルコース等の単糖類はビフィ ドバクテリゥム菌の生残性を 悪くするので好ましくない。 好ましい甘味料は、 シュクロース、 マルト一ス、 ラ ク トース、 パラチノース、 トレハロース、 トレハルロース、 ガラク トオリゴ糖、 ソルビトース、 マルチトール、 パラチニッ ト、 グリチルリチン、 ステピオサイ ド、 レバウディォサイ ド、 サッカリン、 アスパルテーム、 アセスルファーム一 K、 水
飴、 還元水飴等である。 これらの甘味料は、 甘味質向上等の観点から 2種以上を 併用してもよい。 In the sweet food family, monosaccharides such as glucose are not preferred because they deteriorate the survival of Bifidobacterium. Preferred sweeteners are sucrose, maltose, lactose, palatinose, trehalose, trehalulose, galacto-oligosaccharide, sorbitol, maltitol, paratinit, glycyrrhizin, stepioside, rebaudioside, saccharin, aspartame, acesulfame. K, water Candy, reduced syrup, etc. Two or more of these sweeteners may be used in combination from the viewpoint of improving sweetness and the like.
甘味料とその他の添加成分を加えたシロップは、 常法により加熱殺菌し、 冷却 後、 殺菌後添加する成分があるときはそれを添加した後、 前述の乳培養物と混合 する。 The syrup to which the sweetener and other additives have been added is heat-sterilized in a conventional manner, cooled, and after sterilization, if any, is added, and then mixed with the aforementioned milk culture.
シロップ等を混合した乳培養物は、 速やかに酸素遮断性容器に充填する。 また、 酸素遮断性容器を用いるだけでなく、 乳培養物を容器に充填する際、 酸素を含む 空気を容器内に残さないようにすることが望ましい。 そのために有効な手段の一 つは、 容器上部に空間を残さない満量充填を行うことである。 満量充填ができな い場合は、 上部空間の空気を窒素等の不活性気体で置換する方法が有効である。 以下、 実施例を示して本発明を説明する。 なお、 以下の各例において用いた力 テキン類は太陽化学株式会社の茶抽出物精製物 ·サンフ ノン (カテキン類含有 率約 7 0 % ;カテキン、 ガロカチキン、 これらの没食子酸エステル等を含む) で あり、 また用いた精製魚油は、 魚油含有率 2 0 %、 D H A含有率約 5 %の乳化物 でめ 。 Milk culture mixed with syrup, etc. is immediately filled into an oxygen-barrier container. In addition to using an oxygen-barrier container, it is desirable not to leave oxygen-containing air in the container when filling the milk culture with the container. One effective means for this is to perform full filling without leaving any space above the container. If full filling is not possible, it is effective to replace the air in the upper space with an inert gas such as nitrogen. Hereinafter, the present invention will be described with reference to examples. In the following examples, the techins used were the purified tea extract of Taiyo Kagaku Co., Ltd. Sanfunon (catechins content: about 70%; catechins, gallocatins, and gallic esters thereof). Yes, and the refined fish oil used was an emulsion with a fish oil content of 20% and a DHA content of about 5%.
実施例 1 Example 1
加熱殺菌した 2 5 %還元脱脂乳 3 5 0 gにラクトバチルス ·ァシドフィラスの スターターとビフィ ドバクテリゥム · ビフィダムのスターターをそれぞれ 1 %ず つ接種し、 p Hが 5. 2になるまで、 3 7 °Cで培養したのち冷却する。 一方、 人 参ジュース 5 0 g、 砂糖 5 0 g、 およびカテキン類 0. 6 m gに水を加えて全量 を 6 5 0 gにして、 力テキン類を含有するシロップを得る。 このシロップを、 加 熱殺菌後、 上記培養で得られた培養物と混合し、 酸素遮断性容器に充填する。 なお、 上記ヨーグルトの製造過程で、 下記のいずれかに対し、 D H A 1 5 0 m gを含む精製魚油を添加する。 Heat-sterilized 25% reduced skim milk (350 g) was inoculated with 1% of Lactobacillus acidophilus starter and 1% of Bifidobacterium bifidum starter at 37 ° C until the pH reached 5.2. After culturing, cool it. On the other hand, water is added to 50 g of ginseng juice, 50 g of sugar, and 0.6 mg of catechins to make a total amount of 65500 g, thereby obtaining a syrup containing phytotechins. This syrup is sterilized by heating, mixed with the culture obtained by the above culture, and filled in an oxygen-barrier container. In the above yogurt production process, a purified fish oil containing 150 mg of DHA is added to any of the following.
① 培養終了直後の培養物 ① Culture immediately after completion of culture
② 調製後、 加熱殺菌前のシロップ ② Syrup after preparation and before heat sterilization
③ 調製後、 加熱殺菌したシロップ ③ After preparation, heat-sterilized syrup
④ シロップと混合する過程にある培養物 培養 Culture in the process of being mixed with syrup
比較のため、 力テキン類を添加しないほかは上記と同様にしてヨーグルトを製 For comparison, yogurt was prepared in the same manner as above, except that no kinetics were added.
¾Ξ る c ¾Ξ c c
上記方法により得られたヨーグルトについて、 製造直後および 1 0 °Cで 1 4日
間保存後に、 ビフィ ドバクテリゥム菌の生菌数を測定し、 また、 魚臭の有無を調 ベた。 その結果を表 1, 2に示す。 For the yogurt obtained by the above method, immediately after production and at 14 ° C for 14 days After storage for a while, the viable cell count of Bifidobacterium was measured, and the presence or absence of fish odor was examined. Tables 1 and 2 show the results.
表 1 力テキン類を添加した場合 Table 1 When kinetics are added
生菌数/ ^ 1 魚 臭 Viable count / ^ 1 Fish odor
添加対象物 製造直後 14曰保存後 製造直後 14曰保存後 Additives Immediately after production After storage 14 After production After storage 14
① .3x 08 5.4 X 107 全くない 全くない ② .3x 08 5.1 107 全くない 全くない ③ .3x 08 5.3x 107 全くない 全くない ④ .3x 08 5.2x 107 全くない 全くない 表 2 力テキン類無添加の場合 ① .3x 0 8 5.4 X 10 7 Not at all Not at all ② .3x 0 8 5.1 10 7 Not at all Not at all ③ .3x 0 8 5.3x 10 7 Not at all Not at all ④ .3x 0 8 5.2x 10 7 Not at all No Table 2 When no techins are added
生菌数 Zm 1 魚 臭 Viable count Zm 1 Fish odor
添加対象物 製造直後 14曰保存後 製造直後 14曰保存後 Additives Immediately after production After storage 14 After production After storage 14
① 1.3x 08 3.0 X 1 Οβ 全くない ある ② 1.3x 08 3.1 1 Οβ 全くない ある ③ 1.3x 08 3.2 1 Οβ 全くない ある ④ 1.3x 08 3.0 106 全くない ある 実施例 2 ① 1.3x 0 8 3.0 X 1 Ο β No Yes Yes ② 1.3x 0 8 3.1 1 Ο β No Yes Yes ③ 1.3x 0 8 3.2 1 Ο β No Yes Yes ④ 1.3x 0 8 3.0 10 6 No No Some Examples Two
加熱殺菌した 25%還元脱脂乳 350 gにラク トバチルス ·ァシドフィラスの スターターとビフィ ドバクテリゥム · ビフィダムのスターターをそれぞれ 1%ず つ接種し、 pHが 5.2になるまで、 37°Cで培養したのち冷却する。 一方、 人 参ジュース 70g、 パラチノース 120g、 および DHAとして 15 Omgの精 製魚油に水を加えて全量を 650 gにし、 加熱殺菌してシロップを得る。 このシ ロップ 650 gを上記培養で得られた培養物 350 gと混合し、 酸素遮断性容器 に充填して 10°Cに冷却し、 同温度で保存する (保存開始時のビフィ ドバクテリ ゥム菌生菌数: 4.1x 1 O m 1 ) 。 Inoculate 1 g each of a starter of Lactobacillus acidophilus and a starter of Bifidobacterium bifidum on 350 g of heat-sterilized 25% reduced skim milk, incubate at 37 ° C until the pH reaches 5.2, and cool. On the other hand, add water to 70 g of ginseng juice, 120 g of palatinose, and 15 Omg of refined fish oil as DHA to make a total amount of 650 g, and heat sterilize to obtain a syrup. 650 g of this syrup is mixed with 350 g of the culture obtained from the above culture, filled in an oxygen-barrier container, cooled to 10 ° C, and stored at the same temperature (Bifidobacterium at the start of storage) Viable bacteria count: 4.1x1 Om1).
上記方法でヨーグルトを製造するに当たり、 シロップに対してカテキン類また は (および) トコフヱロール類を、 量を種々変更して添加した。 用いたトコフヱ ロール類は、 ビタミン E製剤製造用に市販されている総トコフヱロール含有量 8 0%、 ( —トコフヱロール含有量約 40%のものである。
各ヨーグルトについて、 14日間保存後に、 ビフイ ドバグテリゥム菌の生菌数 を測定し、 また風味を調べた。 その結果を表 3に示す。 In producing yogurt by the above method, catechins and / or tocoproles were added to syrup in various amounts. The tocopherols used are those with a total tocopherol content of 80%, which are commercially available for the production of vitamin E preparations, and a tocopherol content of about 40%. After storage for 14 days for each yogurt, the viable cell count of Bifidobacterium was measured and the flavor was examined. The results are shown in Table 3.
表 3 Table 3
添加物およびその添加量 Lppm〕 生菌数 m 1 風味 Additives and their amounts Lppm) Number of viable bacteria m 1 Flavor
なし 3. 0 X 106 強い魚臭あり カテキン類 0.0001 (1) 3. Ox 106 魚臭あり None 3.0 X 10 6 Strong fish odor Catechin 0.0001 (1) 3. Ox 10 6 Fish odor
0.001 (10) 3. 1 106 僅かに魚臭あり0.001 (10) 3.1 1 10 6 Slightly fishy
0.01 (100) 3. 1 x 106 0.01 (100) 3.1 x 10 6
0.1 (1000) 5. 1 x 107 m , な, 0.1 (1000) 5.1 x 10 7 m
1.0 (104) 5. Ox 107 "なし1.0 (10 4 ) 5. Ox 10 7 "None
10 (105) 5. 1 107 10 (10 5 ) 5.1 1 10 7
100 (1 οβ) 5. Ox 107 . な,100 (1 ο β ) 5. Ox 10 7 .
1000 (107) 5. 2x l07 異味 ·異臭なし 1000 (10 7) 5. 2x l0 7 off-taste, no off-flavors
2000 (2xl07) 5. OxlO7 僅か ' に茶の一風味あり2000 (2xl0 7 ) 5. OxlO 7 Slightly 'with a taste of tea
3000 (3xl07) 5. 1 x 107 苦味 ·渋味あり トコフェロール類 0.0001 (1) 3. 1 1 o6 魚臭あり 3000 (3xl0 7) 5. 1 x 10 7 bitterness, astringency There tocopherols 0.0001 (1) 3. Yes 1 1 o 6 fish odor
0.001 (10) 3. Ox lO6 魚臭あり 0.001 (10) 3.Ox lO 6 Fishy odor
0.01 (100) 3. 2 x 106 僅かに魚臭あり0.01 (100) 3.2 x 10 6 Slightly fishy
0.1 (1000) 5. 1 x 107 僅かに魚臭あり0.1 (1000) 5.1 x 10 7 Slightly fishy
1.0 (104) 5. 2x 107 僅かに魚臭あり1.0 (10 4 ) 5.2 2x 10 7 Slightly fishy
10 (105) 5. 1 x 107 10 (10 5 ) 5.1 x 10 7
100 (106) 5. 1 x 107 100 (10 6 ) 5.1 x 10 7
1000 (107) 5. Oxl O7 1000 (10 7 ) 5.Oxl O 7
2000 (2xl07) 5. 2 x 107 2000 (2xl0 7 ) 5.2 x 10 7
3000 (3xl07) 5. 1 107 僅かに穀物臭あり カテキン類 0.1 (1000) + 3000 (3xl0 7 ) 5.1 1 10 7 Slight grain odor Catechin 0.1 (1000) +
トコフェロール類 0.1 (1000) 5. O lO7 Tocopherols 0.1 (1000) 5.O lO 7
(注:添加量は製品に対する値;ただし括弧内は精製魚油に対する値) 実施例 3 (Note: The amount added is for the product; the values in parentheses are for refined fish oil.) Example 3
無脂乳固形分濃度 23%の加熱殺菌済み還元脱脂乳 380gにストレプトコッ カス ·サーモフィラスとビフィ ドバクテリゥム ·ブレーべのスターターをそれぞ
れ 1%接種し、 ρΗが 5.4になるまで 35 °Cで培養したのち冷却した。 一方、 ブルーン果汁 50 g、 ブドウ糖果糖液糖 75 gおよびカテキン類 1 Omgに水を 加えて全量を 620 gにすることによりシロップを調製し、 それを加熱殺菌後、 上記により得られた培養物に混合した。 380 g of heat-sterilized reduced-fat non-fat milk with a solids concentration of 23% nonfat milk, each with starters of Streptococcus, Thermophilus, Bifidobacterium and Breve After inoculating 1%, the cells were cultured at 35 ° C until ρΗ reached 5.4, and then cooled. On the other hand, syrup was prepared by adding water to 50 g of brune juice, 75 g of glucose fructose syrup, and 1 Omg of catechins to make a total amount of 620 g. Mixed.
得られたドリンクヨーグルト (ビフィ ドバクテリゥム菌生菌数 3.8 X 10V ml) を酸素遮断性密封容器に充填し、 10°Cで 14日間保存した後のビフィ ド パクテリゥム菌生菌数は 4.9x107/mlであり、 風味も良好であった。 実施例 4 The obtained drink yogurt (3.8 x 10 V ml of viable bacteria bacteria) is filled in a sealed oxygen-blocking container and stored at 10 ° C for 14 days. The viable bacteria number of bacteria is 4.9 x 10 7 / ml And the flavor was also good. Example 4
無脂乳固形分濃度 20 %の還元脱脂乳 400 gを 120 °Cで 3秒間加熱したの ちストレプトコッカス ·サーモフィラスとビフィ ドバクテリゥム ·ブレーべのス 夕一ターをそれぞれ 1%接種し、 pHが 4.6になるまで 37°Cで培養した。 得 られた培養物に、 冷却後、 DHAとして 200mgの精製魚油およびシロップを 添加した。 添加したシロップは、 オレンジジュース 50 g、 砂糖 70 g、 ハイメ トキシルぺクチン 3 g、 カテキン類 lmgに水を加えて全量を 600 gにし、 115°Cで 3秒間加熱して殺菌したものである。 After heating 400 g of reduced skim milk with a non-fat milk solids concentration of 20% at 120 ° C for 3 seconds, 1% of Streptococcus thermophilus and Bifidobacterium breve starch were inoculated at 1% each to adjust the pH to 4.6. Culture was performed at 37 ° C until complete. After cooling, 200 mg of purified fish oil and syrup as DHA were added to the obtained culture. The added syrup was made by adding water to 50 g of orange juice, 70 g of sugar, 3 g of high-methoxyl pectin, and lmg of catechins to make a total volume of 600 g, and sterilized by heating at 115 ° C for 3 seconds.
精製魚油およびシロップを混合した培養物は 150 k g Z c m 2で均質化した のち酸素遮断性密封容器に充填した。 得られたドリンクヨーグルト (ビフィ ドバ クテリゥム菌生菌数 3.2 1 O m 1 ) は 10°Cで 14日間保存した後も全く 魚臭を感じさせず、 また、 その中のビフィ ドバクテリゥム菌生菌数は 6.0 X 1 O m 1を維持していた。 The culture in which the purified fish oil and the syrup were mixed was homogenized at 150 kg Z cm 2 and then filled in an oxygen-tight sealed container. The obtained drink yoghurt (Bifidobacterium viable cell count 3.21 O m 1) did not show any fishy odor even after being stored at 10 ° C for 14 days, and the viable bacterial cell count in it was 6.0 X 1 Om1 was maintained.
実施例 5 Example 5
25%還元脱脂乳 350 gを加熱殺菌後、 ラク トバチルス ·ァシドフィラスの スターターとビフィ ドバクテリゥム ·インファンティスのスターターをそれぞれ After heat-sterilizing 350 g of 25% reduced skim milk, starters of Lactobacillus acidophilus and Bifidobacterium infantis were used, respectively.
1%接種して1311が5.3になるまで培養した。 The cells were inoculated with 1% and cultured until 1311 became 5.3.
別に、 人参ジュース 50g、 パラチノース 120g、 カテキン類 lmg、 トコ フヱロール類 (総トコフヱロール含有量 80%、 (5—トコフヱロール含有量約 2 5%、 α—トコフヱロール含有量約 15%) lmg, および DHAとして 100 mgの精製魚油に水を加えて全量を 650 gにし、 120°Cに 3秒間加熱して殺 菌したのち 10°C以下に冷却した。 Separately, 50 g of ginseng juice, 120 g of palatinose, lmg of catechins, tocoproles (total content of tocopherol 80%, (5-tocopherol content of about 25%, α-tocopherol content of about 15%) lmg, and DHA of 100 Water was added to mg of purified fish oil to make the total amount 650 g, and the mixture was heated to 120 ° C for 3 seconds to kill bacteria, and then cooled to 10 ° C or less.
得られたシロップを上記培養による培養物と混合して得られたドリンクョーグ ルト (ビフィ ドバクテリゥム菌生菌数 3.5x108Zml) を、 酸素遮断性密封
容器に充填して 10°Cで保存した。 14曰後、 開封して検査したところ、 製品は 全く魚臭を感じさせず、 また、 ビフィ ドバクテリゥム菌生菌数は 5.3x10 m 1を維持していた。 The resulting syrup was mixed with the culture of the above culture, and the resulting drink (3.5 x 10 8 Zml of Bifidobacterium viable bacteria) was sealed in an oxygen-tight seal. The container was filled and stored at 10 ° C. 14 After opening and inspecting, the product showed no fishy odor at all, and the viable bacterial count of Bifidobacterium was maintained at 5.3x10 m1.
実施例 6 Example 6
20%還元脱脂乳 400 gを加熱殺菌後、 ストレプトコッカス ·サーモフィラ スのスターターとビフィ ドバクテリゥム ·ァドレツセンテイスのスターターをそ れぞれ 1%接種して、 pHが 4.5になるまで 37°Cで培養した。 得られた培養 物は、 冷却後、 均質化した。 After heat-sterilizing 400 g of 20% reduced skim milk, inoculate 1% each of a starter of Streptococcus thermophilus and a starter of Bifidobacterium adrecentesensis, and incubate at 37 ° C until pH reaches 4.5. Cultured. The resulting culture was homogenized after cooling.
別にストロベリージュース 50 g、 マルトース 200 g、 カテキン類 1.5m g、 ゼラチン 10 gを水に溶解し、 全量を 650 gにして加熱殺菌した。 その後、 適量の香料および DHAとして 18 Omgの精製魚油を混合した。 Separately, 50 g of strawberry juice, 200 g of maltose, 1.5 mg of catechins, and 10 g of gelatin were dissolved in water, and the total amount was made 650 g and sterilized by heating. Thereafter, an appropriate amount of flavor and 18 Omg of purified fish oil as DHA were mixed.
得られたシ口ップを上記均質化済み培養物に混合し、 得られたハードョーグル ト (ビフィ ドバクテリゥム菌生菌数 2.9x108Zml) を、 酸素遮断性密封容 器に充填して 10°Cで保存した。 14曰後、 開封して検査したところ、 製品は全 く魚臭を感じさせず、 また、 ビフィ ドバクテリゥム菌生菌数は 4.8x10 V m 1を維持していた。 The resulting sheet opening-up and mixed into the homogenized pre culture, resulting Hadoyoguru preparative (Bifi Dobakuteriumu bacteria bacteria number 2.9x10 8 ZML), and filled into oxygen blocking hermetic container 10 ° C Saved in. 14 After opening and inspecting, the product showed no fishy smell, and the viable bacterial count of Bifidobacterium was maintained at 4.8x10 V ml.
産業上の利用の可能性 Industrial applicability
上述のように、 本発明によれば、 ヨーグルトの本来の風味を損なうことなしに、 簡単かつ確実にビフィ ドバクテリゥム菌の生残性を向上させ、 保健効果のすぐれ たビフィ ドバクテリウム菌含有ョ一グルトを提供することができる。 As described above, according to the present invention, it is possible to easily and reliably improve the survival of Bifidobacterium bacteria without impairing the original flavor of yogurt, and to obtain a Bifidobacterium-containing monogurt having an excellent health effect. Can be provided.
さらに、 精製魚油を添加されたヨーグルトの場合は、 ビフィ ドバクテリゥム菌 生残性がすぐれているだけでなく保存中の魚臭発現がほとんどないので、 風味悪 化を招くおそれなしに DH A、 E P A等の高度不飽和脂肪酸を十分に含有させた ビフィ ドバクテリゥム菌入りヨーグルトを提供することが可能になる。
Furthermore, in the case of yogurt to which refined fish oil has been added, not only Bifidobacterium survivability is excellent, but also there is almost no fish odor during storage, so that DHA, EPA, etc. It is possible to provide a yoghurt containing Bifidobacterium, which sufficiently contains the polyunsaturated fatty acid.
Claims
1 . 乳酸菌と共にビフィ ドバクテリゥム菌を含有するヨーグルトにおいて、 力 テキン類を含有することを特徴とするヨーグルト。 1. A yogurt containing bifidobacteria along with lactic acid bacteria, which comprises phytotechins.
2. 乳酸菌と共にビフイ ドパクテリゥム菌を含有するヨーグルトにおいて、 2 0 0 0 p p m以下のトコフユロール類を含有することを特徴とするョーグルト。 2. Yogurt containing bifidobacterium along with lactic acid bacteria, wherein the yogurt contains not more than 2000 ppm of tocofurols.
3 . 乳酸菌と共にビフィ ドバクテリゥム菌を含有するヨーグルトにおいて、 力 テキン類およびトコフユロール類を含有することを特徴とするヨーグルト。 3. A yogurt containing bifidobacteria along with lactic acid bacteria, which contains phytotechins and tocofurols.
4. カテキン類およびトコフ ロール類の含有率がそれぞれ 0. 1〜2 0 0 0 p p mである請求の範囲第 3項に記載のョ一グルト。 4. The yogurt according to claim 3, wherein the content of each of the catechins and the tocofurols is 0.1 to 2000 ppm.
5. ョーダルトが精製魚油を添加されたものである請求の範囲第 1項ないし第 4項の L、ずれかに記載のョ一グルト。 5. The yogurt according to any one of claims 1 to 4, wherein the yogurt is obtained by adding refined fish oil.
6. ヨーグルトが精製魚油を添加されたものでありカテキン類および/または トコフユロール類の含有率がそれぞれ精製魚油に対して 1 0 0 p p m以上である 請求の範囲第 1項ないし第 4項のいずれかに記載のヨーグルト。 6. The yogurt to which refined fish oil has been added, and the content of catechins and / or tocofurols is 100 ppm or more based on refined fish oil, respectively, any one of claims 1 to 4. The yogurt described in the above.
7 . 乳酸菌およびビフィ ドバクテリゥム菌を乳培地に接種して培養し、 得られ た培養物にシロップを混合してビフィ ドバクテリゥム菌を含有するヨーグルトを 製造するに当たり、 カテキン類およびトコフエロール類を添加されたシロップを 培養物に混合することを特徴とするビフィ ドバクテリゥム菌を含有するョ一ダル トの製造法。 7. Lactic acid bacteria and Bifidobacterium are inoculated and cultured in a milk medium, and syrup is mixed with the obtained culture to produce yoghurt containing Bifidobacterium, and syrup containing catechins and tocopherols is added. A method for producing boulder bacteria containing bifidobacteria, which is characterized in that the method is mixed with a culture.
8. 乳酸菌およびビフィ ドバクテリゥム菌を乳培地に接種して培養し、 得られ た培養物にシ口ップおよび精製魚油を混合して精製魚油とビフィ ドバクテリウム 菌を含有するヨーグルトを製造するに当たり、 カテキン類およびトコフヱロール 類からなる群から選ばれた 1種以上の化合物ならびに精製魚油をシ口ップに添加 し、 該添加後のシロップを培養物に混合することを特徴とするビフィ ドバクテリ ゥム菌を含有するヨーグルトの製造法。
8. Lactic acid bacteria and Bifidobacterium are inoculated and cultured in a milk medium, and the obtained culture is mixed with purified fish oil and refined fish oil to produce yogurt containing purified fish oil and Bifidobacterium bacteria. And at least one compound selected from the group consisting of tocopherols and tocoproles, and purified fish oil are added to a soup, and the syrup after the addition is mixed with the culture. A method for producing a contained yogurt.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU57799/96A AU5779996A (en) | 1995-05-26 | 1996-05-24 | Yoghurt containing bifidobacterium and process for producing the same |
KR1019970706887A KR19980703483A (en) | 1995-05-26 | 1996-05-24 | Yogurt containing Bifidobacterium bacteria and its preparation method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7/151108 | 1995-05-26 | ||
JP7151108A JPH08322464A (en) | 1995-05-26 | 1995-05-26 | Yogurt containing Bifidobacterium and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996037113A1 true WO1996037113A1 (en) | 1996-11-28 |
Family
ID=15511533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/001401 WO1996037113A1 (en) | 1995-05-26 | 1996-05-24 | Yoghurt containing bifidobacterium and process for producing the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPH08322464A (en) |
KR (1) | KR19980703483A (en) |
AU (1) | AU5779996A (en) |
TW (1) | TW501912B (en) |
WO (1) | WO1996037113A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002037976A1 (en) * | 2000-11-13 | 2002-05-16 | Nippon Suisan Kaisha, Ltd. | Epa and/or dha-containing acidic milks |
WO2004050892A1 (en) * | 2002-12-05 | 2004-06-17 | Hongrim Trading Co., Ltd. | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof |
EP1201132A4 (en) * | 1999-08-03 | 2004-12-15 | Yakult Honsha Kk | BEVERAGES AND FOODS BASED ON FERMENTED MILK AND PROCESS FOR THE PRODUCTION THEREOF |
WO2007009187A1 (en) * | 2005-07-22 | 2007-01-25 | Tarac Technologies Pty Ltd | Polyphenol and probiotic containing nutritional supplement |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101454281B1 (en) * | 2006-04-13 | 2014-10-27 | 가부시키가이샤 메이지 | Fermented milk of rubbery fat solid and / or low fat having good flavor and method for producing the same |
WO2007124992A1 (en) * | 2006-04-28 | 2007-11-08 | Unilever N.V. | Method of manufacturing a cultured edible product comprising omega-3 polyunsaturated fatty acids |
AU2007245762B2 (en) * | 2006-04-28 | 2011-02-24 | Unilever Plc | Method of manufacturing an edible product comprising fruit and omega-3 polyunsaturated fatty acids |
JP4898859B2 (en) * | 2009-03-05 | 2012-03-21 | 森永乳業株式会社 | Non-fermenting acidic lactic acid bacteria beverage and method for producing the same |
JP7177039B2 (en) * | 2017-03-16 | 2022-11-22 | 株式会社明治 | Phytochemical absorption enhancer |
EP3763218B8 (en) * | 2018-03-07 | 2025-09-10 | Fuji Oil Co., Ltd. | Method for producing a highly unsaturated fatty acid-containing food product |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0698717A (en) * | 1992-09-17 | 1994-04-12 | Meiji Milk Prod Co Ltd | Liquid nutritive food prepared for long-term patient |
WO1994026133A1 (en) * | 1993-05-11 | 1994-11-24 | Otsuka Pharmaceutical Co., Ltd. | Antioxidant food, antioxidant preparation and antioxidization method |
JPH07107907A (en) * | 1993-10-15 | 1995-04-25 | Kiteii:Kk | Production of fat and oil emulsion |
JPH08169A (en) * | 1994-06-15 | 1996-01-09 | Kazuoki Ishihara | Fermentation mixture for making fermented food products |
-
1995
- 1995-05-26 JP JP7151108A patent/JPH08322464A/en active Pending
-
1996
- 1996-05-24 KR KR1019970706887A patent/KR19980703483A/en not_active Ceased
- 1996-05-24 AU AU57799/96A patent/AU5779996A/en not_active Abandoned
- 1996-05-24 WO PCT/JP1996/001401 patent/WO1996037113A1/en not_active Application Discontinuation
- 1996-05-29 TW TW085106388A patent/TW501912B/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0698717A (en) * | 1992-09-17 | 1994-04-12 | Meiji Milk Prod Co Ltd | Liquid nutritive food prepared for long-term patient |
WO1994026133A1 (en) * | 1993-05-11 | 1994-11-24 | Otsuka Pharmaceutical Co., Ltd. | Antioxidant food, antioxidant preparation and antioxidization method |
JPH07107907A (en) * | 1993-10-15 | 1995-04-25 | Kiteii:Kk | Production of fat and oil emulsion |
JPH08169A (en) * | 1994-06-15 | 1996-01-09 | Kazuoki Ishihara | Fermentation mixture for making fermented food products |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1201132A4 (en) * | 1999-08-03 | 2004-12-15 | Yakult Honsha Kk | BEVERAGES AND FOODS BASED ON FERMENTED MILK AND PROCESS FOR THE PRODUCTION THEREOF |
US7115291B1 (en) | 1999-08-03 | 2006-10-03 | Kabushiki Kaisha Yakult Honsha | Fermented milk drinks and foods and process for producing the same |
US7927638B2 (en) | 1999-08-03 | 2011-04-19 | Kabushiki Kaisha Yakult Honsha | Fermented milk drinks and foods and process for producing the same |
WO2002037976A1 (en) * | 2000-11-13 | 2002-05-16 | Nippon Suisan Kaisha, Ltd. | Epa and/or dha-containing acidic milks |
US7651720B2 (en) | 2000-11-13 | 2010-01-26 | Nippon Suisan Kaisha, Ltd. | EPA and/or DHA-containing acidic milks |
WO2004050892A1 (en) * | 2002-12-05 | 2004-06-17 | Hongrim Trading Co., Ltd. | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof |
AU2003284785B2 (en) * | 2002-12-05 | 2009-12-03 | Kuan Industrial Co., Ltd | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof |
US7754252B2 (en) | 2002-12-05 | 2010-07-13 | Kuan Industrial Co., Ltd. | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof |
WO2007009187A1 (en) * | 2005-07-22 | 2007-01-25 | Tarac Technologies Pty Ltd | Polyphenol and probiotic containing nutritional supplement |
Also Published As
Publication number | Publication date |
---|---|
TW501912B (en) | 2002-09-11 |
JPH08322464A (en) | 1996-12-10 |
KR19980703483A (en) | 1998-11-05 |
AU5779996A (en) | 1996-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6599543B1 (en) | Process for preparing fermented soybean milk | |
EP0809939B1 (en) | Yogurt | |
CA2426854C (en) | Acidified milk containing epa and/or dha | |
KR20150041519A (en) | latic acid bacteria fruit fermented liquor, latic acid bacteria fermentation fruit beverage and manufacturing method thereof | |
CN102159092A (en) | Fermented product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same | |
JP4913231B2 (en) | Process for producing food and drink containing 1,4-dihydroxy-2-naphthoic acid (DHNA) | |
WO1996037113A1 (en) | Yoghurt containing bifidobacterium and process for producing the same | |
AU2008215497B2 (en) | Agent for improving viability of lactic acid bacterium | |
JP4898859B2 (en) | Non-fermenting acidic lactic acid bacteria beverage and method for producing the same | |
WO1998012931A1 (en) | Lactic acid bacteria fermented milk in which increase in acidity is suppressed | |
KR20020043228A (en) | Fermented foods containing bifidobacterium | |
EP0521166B1 (en) | Lactic acid bacterium starter, containing peroxidase, fermented milk product, and production thereof | |
JP5980934B2 (en) | Fermented dairy products enriched with iron and tocopherol | |
JP3238554B2 (en) | Production method of coffee beverage containing dairy ingredients | |
MXPA06010751A (en) | Shelf stable product with living micro-organisms. | |
KR102416803B1 (en) | Development of fermented vegetable lactic acid bacteria beverage packed with spout pouch for room temperature distribution using batch type sterilization and after-sterilization process | |
JP3007686B2 (en) | Lactic acid bacterium starter containing peroxidase, fermented milk product, and methods for producing the same | |
BR102023013021A2 (en) | FORMULATION OF FERMENTED MILK BASED ON KEFIR FLAVORED WITH MANILKARA ZAPOTA PULP POWDER WITH GUM ARABIC | |
RU2013061C1 (en) | Method for production of low-caloric cultured-milk product for baby and dietary food | |
RU2041666C1 (en) | Process for manufacture of fermented fruit beverage | |
Brandao | Determination of volatile flavor constituents and residual carbohydrates during the fermentation of yogurt | |
JPH06253734A (en) | Method for improving survivability of bifidus | |
JAGTAP | DAIRY SCIENCE | |
JPH09252722A (en) | Retention of quality of milk-containing food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CN KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BE DE DK FR GB SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1019970706887 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 1019970706887 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019970706887 Country of ref document: KR |